MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: New combination therapy safe, promising for melanoma

Back to cancer blog Blogs list Cancer blog  


Subscribe To Cancer Blog RSS Feed  RSS content feed What is RSS feed?

New combination therapy safe, promising for melanoma




The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, as per a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

Scientists in the melanoma and skin cancer program at UPCI combined two biotherapies therapys that stimulate the immune system to fight cancer and found the results promising in terms of anti-tumor effects and tolerable in terms of toxicity. High-dose interferon alfa-2b, a standard therapy for metastatic skin cancer, and tremelimumab, an antibody thought to instigate the bodys immune system to attack tumors, were combined for the first time in this phase 2 clinical trial.



New combination therapy safe, promising for melanoma

With each new study, we learn something important about melanoma, said John M. Kirkwood, M.D., leader of the program and professor and vice chairman for clinical research in the Department of Medicine, University of Pittsburgh School of Medicine. With this study, we learned that adding tremelimumab to traditional therapy is not only safe, but an effective way to induce an anti-tumor response, which is very exciting.

For this study, 16 patients diagnosed with stage 4 melanoma, all of whom received and had not benefited from at least one round of prior treatment, were given the combination therapy. The overall response rate was 19 percent, and the study has since moved into the second stage, where it will enroll 21 additional patients.

Melanoma is a rare form of skin cancer, but it causes the majority of skin cancer-related deaths. Each year, approximately 160,000 new cases are diagnosed worldwide, and currently surgery is the only effective cure. For patients with inoperable disease, like those enrolled in this study, discovering a safe and effective therapy is vital.


Posted by: Janet    Source




Did you know?
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, as per a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Scientists in the melanoma and skin cancer program at UPCI combined two biotherapies therapys that stimulate the immune system to fight cancer and found the results promising in terms of anti-tumor effects and tolerable in terms of toxicity. High-dose interferon alfa-2b, a standard therapy for metastatic skin cancer, and tremelimumab, an antibody thought to instigate the bodys immune system to attack tumors, were combined for the first time in this phase 2 clinical trial.

Medicineworld.org: New combination therapy safe, promising for melanoma

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.